(Reuters) - NEW YORK, April 16 - Eli Lilly and Co. reported lower first-quarter profit on Monday as special charges offset higher sales of the company's array of prescription medicines.
Earnings fell to $508.7 million, or 47 cents per share, from $835 million, or 77 cents per share, a year earlier.
Read more at Reuters.com Market News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment